PROM1 and gastric carcinoma: The authors of the original article “Evaluation of METase-Pemetrexed-Loaded PEG-PLGA Nanoparticles Modified with Anti-CD133-scFV for Treatment of Gastric Carcinoma” (Biosci Rep (2018) 38(1), DOI: 10.1042/BSR20171001) would like to correct Figure 2C. During the authors' figure build of Figure 2C, the migration images in the “CD133-” group and the “CD133+” group had been switched.